Cargando…
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361079/ https://www.ncbi.nlm.nih.gov/pubmed/32679279 http://dx.doi.org/10.1016/j.jaad.2020.07.021 |
_version_ | 1783559338084794368 |
---|---|
author | Georgakopoulos, Jorge R. Mufti, Asfandyar Vender, Ron Yeung, Jensen |
author_facet | Georgakopoulos, Jorge R. Mufti, Asfandyar Vender, Ron Yeung, Jensen |
author_sort | Georgakopoulos, Jorge R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7361079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | by the American Academy of Dermatology, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73610792020-07-15 Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study Georgakopoulos, Jorge R. Mufti, Asfandyar Vender, Ron Yeung, Jensen J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-10 2020-07-15 /pmc/articles/PMC7361079/ /pubmed/32679279 http://dx.doi.org/10.1016/j.jaad.2020.07.021 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Letter Georgakopoulos, Jorge R. Mufti, Asfandyar Vender, Ron Yeung, Jensen Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study |
title | Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study |
title_full | Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study |
title_fullStr | Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study |
title_full_unstemmed | Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study |
title_short | Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study |
title_sort | treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the covid-19 pandemic: a canadian multicenter retrospective study |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361079/ https://www.ncbi.nlm.nih.gov/pubmed/32679279 http://dx.doi.org/10.1016/j.jaad.2020.07.021 |
work_keys_str_mv | AT georgakopoulosjorger treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy AT muftiasfandyar treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy AT venderron treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy AT yeungjensen treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy |